| 000 | 01126 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515044211.0 | ||
| 264 | 0 | _c20070109 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0020-8167 | ||
| 024 | 7 |
_a10.1097/01.iio.0000212130.91136.31 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKatz, Barrett | |
| 245 | 0 | 0 |
_aMacugen (pegaptanib sodium), a novel ocular therapeutic that targets vascular endothelial growth factor (VEGF). _h[electronic resource] |
| 260 |
_bInternational ophthalmology clinics _c2006 |
||
| 300 |
_a141-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAptamers, Nucleotide _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacular Degeneration _xcomplications |
| 650 | 0 | 4 |
_aRetinal Neovascularization _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aGoldbaum, Mauro | |
| 773 | 0 |
_tInternational ophthalmology clinics _gvol. 46 _gno. 4 _gp. 141-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.iio.0000212130.91136.31 _zAvailable from publisher's website |
| 999 |
_c16635671 _d16635671 |
||